Target intelligence / Profile preview

Antisense transcript to presenilin 2

Molecular classification
Other (non-coding RNA, antisense transcript)
01

Overview

Antisense transcript to presenilin 2 (PSEN2) is a non-coding RNA that is transcribed from the DNA strand opposite to the PSEN2 gene. Although antisense transcription is a widespread feature in mammalian genomes, specific functional characterization of the antisense transcript to PSEN2 is not available in current literature. Generally, antisense RNAs regulate gene expression and chromatin structure at their loci, and may affect transcript production and stability of the sense gene (here, PSEN2)[3]. Since PSEN2 is associated with Alzheimer's disease through its role in the γ-secretase complex[1][2][4][6], alterations in antisense activity could theoretically modulate PSEN2 expression and downstream disease mechanisms. However, this antisense transcript is not a canonical therapeutic target, and no drugs, biomarkers, or safety issues are described in relation to it. Important contextual notes: - The provided Ensembl identifier (ENSG00000303134) is not standard (Ensembl gene IDs are usually of the form ENSG000001xxxxxx). There may be an annotation or data entry error. - No direct evidence supports this antisense transcript as a recognized drug target, receptor, enzyme, transporter, or marker. - Most research regarding PSEN2 focuses on its protein and coding transcripts related to Alzheimer's disease and other pathologies[1][2][4][6].

Other names
Antisense transcript to PSEN2PSEN2 antisense RNAPSEN2-AS (hypothetical)
02

Biological functions

Epigenetic regulation of PSEN2 expression[3]Modulation of chromatin structure and transcription dynamics[3]Possible influence on transcript production and stability[3]
03

Disease associations

Potential involvement in neurodegenerative disease by regulating PSEN2 expression, which is implicated in Alzheimer's disease[4]Other (no direct evidence of disease involvement)

Beyond the preview

Go deeper on Antisense transcript to presenilin 2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Antisense transcript to presenilin 2.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call